Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents. Our goal is to build on therapeutics with well-known pharmacology by improving their safety and efficacy as well as broadening their potential field of use.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Change (%)0.00 (0.00%)
Data as of 11/30/15 4:00 p.m. ET
Refresh quote

Corporate Presentation

Download Documentation Corporate Presentation November 2015

Recent News

More >>
11/10/15Heron Therapeutics to Participate in Investor Conferences in November 2015Printer Friendly Version
11/06/15Heron Therapeutics Announces Third Quarter 2015 Financial Results and Recent Corporate ProgressPrinter Friendly Version
10/12/15Heron Therapeutics Appoints Neil J. Clendeninn, M.D., Ph.D. as Senior Vice President and Chief Medical OfficerPrinter Friendly Version
09/28/15Heron Therapeutics Announces Oral Presentation of Data from Completed Phase 3 MAGIC Study for SUSTOL® at the ASCO Breast Cancer SymposiumPrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.